Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva Gets Upgrade on Revenue Growth
TheStreet.com
Wednesday, January 11, 2012 - 12:00pm
tags:
Teva Pharmaceuticals
Cubist's Preliminary Sales Impress
Yahoo/Zacks.com
Wednesday, January 11, 2012 - 11:59am
tags:
Cubist Pharmaceuticals
Analyst gauges financial loss from Novartis recall
Yahoo/AP
Wednesday, January 11, 2012 - 11:55am
tags:
Novartis, recalls
Can These 5 Pharma Stocks Keep Paying Big Dividends?
Seeking Alpha
Wednesday, January 11, 2012 - 11:55am
tags:
Abbott Laboratories, GSK, Eli Lilly, Merck, Pfizer
A Conflicted FDA Panel, Bayer & Birth Control Pills
Pharmalot
Wednesday, January 11, 2012 - 10:59am
tags:
FDA, Yaz, Yasmin, birth control pill, Bayer
Celldex Therapeutics: A Potential Triple With Data On The Way
Seeking Alpha
Wednesday, January 11, 2012 - 10:58am
tags:
Celldex, Amgen, Bristol-Myers Squibb, Dendreon, Seattle Genetics, Exelixis
Against The Grain: Abbott Is Not Worth Your Money Now
Seeking Alpha
Wednesday, January 11, 2012 - 10:57am
tags:
Abbott Laboratories, Eli Lilly, Merck, Pfizer
Dendreon posied to get decent mark from German regulator, says RBC Capital
The Fly on the Wall
Wednesday, January 11, 2012 - 10:56am
tags:
Dendreon, Germany
Yield Chasers: Pfizer's 4% Dividend Is Very Appealing
Seeking Alpha
Wednesday, January 11, 2012 - 10:55am
tags:
Pfizer, dividends
Sanofi CEO Is Open to Deals of Up to $2.6 Billion This Year
Bloomberg
Wednesday, January 11, 2012 - 10:55am
tags:
Sanofi, Pharma CEOs, M&A, Chris Viehbacher
2012 Preview: Merck
Motley Fool
Wednesday, January 11, 2012 - 10:54am
tags:
Merck
Life Tech, Illumina unveil one-day genomes
Marketwatch
Tuesday, January 10, 2012 - 6:05pm
tags:
Life Technologies, Illumina, genomes
Arena says FDA accepts new filing for obesity drug lorcaserin, will make decision by June 27
Yahoo/AP
Tuesday, January 10, 2012 - 6:04pm
tags:
Arena, FDA, obesity, lorcaserin
Merck: 6 Reasons This Stock Is Dead Money
Seeking Alpha
Tuesday, January 10, 2012 - 5:57pm
tags:
Merck
J&J Sold Insulin Pumps After Learning of Defects, FDA Says
Bloomberg
Tuesday, January 10, 2012 - 5:05pm
tags:
insulin pumps, JNJ, FDA, diabetes
Bristol CEO sees fruits of company transformation
Yahoo/AP
Tuesday, January 10, 2012 - 5:05pm
tags:
Pharma CEOs, Bristol-Myers Squibb, Lamberto Andreotti
Pfizer CEO focused on reorganizing research, creating more partnerships, allocating capital
Yahoo/AP
Tuesday, January 10, 2012 - 12:33pm
tags:
Pfizer, Ian Read, reorganization, R&D, Pharma CEOs
Shire gets U.S. rights to Resolor from Janssen
The Fly on the Wall
Tuesday, January 10, 2012 - 12:32pm
tags:
Janssen, Shire, Resolor
Dendreon: The Surge Continues
Seeking Alpha
Tuesday, January 10, 2012 - 9:51am
tags:
Dendreon, Provenge
3 Reasons Hep C Premiums Might Not Last
Motley Fool
Tuesday, January 10, 2012 - 9:50am
tags:
hepatitis C, Anadys, Roche, Gilead, Pharmasset, Bristol-Myers Squibb, Inhibitex

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.